SCHEMBL25818392

SCHEMBL25818392

CC1(C)OB(c2cccc(-c3ccc4c(-c5ccccc5)cccc4c3)c2)OC1(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 9/20 0.55
LPL P06858 8/20 0.55
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
PDGFRB P09619 1/20 0.37
KDR P35968 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MPI P34949 1/20 0.35
KMT2A Q03164 1/20 0.35
ENPP3 O14638 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25681116 0.96 LIPG (0.57) LIPGLPLHSD17B1HSD17B2PDGFRB
SCHEMBL25681122 0.92 LIPG (0.63) LIPGLPLHSD17B1HSD17B2PRMT5
SCHEMBL24377393 0.92 LIPG (0.63) LIPGLPLHSD17B1HSD17B2PDGFRB
SCHEMBL25681121 0.92 LIPG (0.51) LIPGLPLHSD17B1HSD17B2CA12
SCHEMBL15197459 0.91 LIPG (0.56) LIPGLPLPDGFRBKDRCA12
SCHEMBL15197472 0.91 LIPG (0.56) LIPGLPLPDGFRBKDRCA12
SCHEMBL25799120 0.91 LIPG (0.55) LIPGLPLPDGFRBKDRPRMT5
SCHEMBL15197464 0.90 LIPG (0.55) LIPGLPLPDGFRBKDRCA12
SCHEMBL24377078 0.89 LIPG (0.65) LIPGLPLHSD17B1HSD17B2CA12
SCHEMBL26279926 0.89 LIPG (0.49) LIPGLPLHSD17B1HSD17B2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 LIPG 2250/4885LPL 2100/4885HSD17B1 3460/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 LIPG 2250/4885LPL 2100/4885HSD17B1 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.